Delivery Order SPE2DB20D3101-SPE2DB25FRMT3
Award Date
6/11/25
Potential Completion Date
6/12/25
Potential Value
$6.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,547.13, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,062.84 and a period of performance through May 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product, with a ceiling value of $15,588.85 and a period of performance ending on May 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,542.20, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract has a completion date of February 25, 2025 and is a firm fixed-price delivery order. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MYFEMBREE, a specialty medication, and has a ceiling value of $1,632.41. The contract is a firm fixed-price Indefinite Delivery Vehicle (IDV) with a period of performance through January 2025. The contract is not designated as a set-aside and was awarded through open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,295.88 firm fixed-price delivery order contract is for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with an ultimate completion date of October 27, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,566.86, is for the supply of the drug MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. It is a firm fixed-price delivery order contract with an ultimate completion date of April 1, 2025. The contract is not set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award, valued at $1,557.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S pharmaceutical products. The contract, which runs until January 8, 2025, is a firm fixed price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a significant Indefinite Delivery Contract (IDC)...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation. The contract delivers MYFEMBREE 40/1/0.5 28S, a pharmaceutical product, with a ceiling value of $2,475.00 and a performance period through March 18, 2024. This award does not have a set-aside designation. Amerisourcebergen Drug Corporation holds an indefinite delivery contract (IDC) with DLA valued up...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,480.80, is a delivery order for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S. The contract has a firm fixed price and an ultimate completion date of February 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...